Ahead of print
Short-term Outcomes in D2 Dissection in Laparoscopic versus Open Gastrectomy for Gastric Cancer
Ali Zedan, Haisam A. Samy, Tark Salah, Marwa T. Hussien
Ahead of print
Article DOI: 10.21614/sgo-25-5-295
Read article Background: Surgical resection with en-bloc lymphadenectomy is the hallmark of curative therapy for gastric cancer patients. The favoured surgical technique worldwide has been open gastrectomy for a long time. This procedure however, is connected to significant morbidity. Compared to open procedures, multiple meta-analyses have demonstrated a benefit in the short-term results of laparoscopic gastrectomy.


Objective: Comparison of the short-term advantages of radical gastrectomy with dissection D2 (laparoscopic and open in gastric cancer patients).....[more]
Therapeutic Lateral Neck Dissection in Papillary Thyroid Carcinoma
Ali Zedan1, Waleed Ahmed Diab, Hemat A. Mahmoud, Haisam Atta
Ahead of print
Article DOI: 10.21614/sgo-25-5-310
Read article Objective: Papillary thyroid carcinoma (PTC) has a high rate of lateral neck node metastases, lymph node metastasis (LNM) is a vital prognosis factor. The aim of this study was to evaluate morbidity and outcomes of therapeutic lateral neck dissection papillary thyroid cancer (PTC) with lateral lymph node metastasis (LLNM).

Methods: We conducted a retrospective analysis of 78 PTC patients who underwent neck dissections for the management of lateral cervical metastases from January 2010 and January 2020.

Results: 35.9% and 16.7% presented multif....[more]
Pemphigus in a Patient Treated with Immune Checkpoint Inhibitor for Advanced Cutaneous Squamous Cell Carcinoma
Katia Lanzafame, Maria Carmela Careri, Vitalinda Pumo, Gabriella Buccafusca, Salvatore Lo Bianco, Paolo Tralongo
Ahead of print
Article DOI: 10.21614/sgo-598
Read article

Cutaneous squamous cell carcinoma is the second most common skin cancer. Cemiplimab, an antiPD-1 monoclonal antibody, is the first immunotherapy approved for patients with locally advanced cSCC. Phase I and II studies showing high antitumor activity and good tolerability of cemiplimab. However, very little data is available on cemiplimab in real life and in frail, elderly and immunocompromised patients. We report the case of an elderly patient (84 years old) affected by metastatic cSCC. The patient performed 16 cycles of treatment with cemiplimab with complete pathological respons....[more]

Computed Tomography in the Diagnosis of Neuroendocrine Tumors of the Pancreas
Mircea Stoian, Radu Ionescu
Ahead of print
Article DOI: 10.21614/sgo-605
Read article

Neuroendocrine tumors of the pancreas (NETP) are rare malignancies that originate from pancreatic neuroendocrine cells and may be functional in nature through the clinical picture secondary to hormonal hypersecretion. These tumors can be detected incidentally by imaging in patients presenting with specific syndromes or as a result of the mass, volumetric effect of metastases and primary tumors. This article presents two cases diagnosed with NETP, of two men aged 58 and 77 years respectively in the Hospital, detected by CT and subsequently confirmed histopathologically, who present....[more]

Cerebral Toxoplasmosis in an HIV-infected Patient
Mircea Stoian, Radu Ionescu
Ahead of print
Article DOI: 10.21614/sgo-608
Read article

Toxoplasma gondii is a parasitic infection widespread worldwide, being the prerogative of AIDS patients. We present a case of reactivated T. gondii in a 30-year-old, HIV-positive patient who presented with secondary partial and generalized seizures, hepatitis C virus infection, hematological abnormalities. MRI examination identifies a 14/12 mm left paramedian cortico-subcortical lesion with intense peripheral contrast uptake and associated edema. The importance of cerebral radiographic examination in HIV patients is discussed in this paper.


INTRODUCTION

Toxoplasm....[more]


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Mar 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/